A miniaturized cell-mediated cytotoxicity assay with human effector mononuclear cells

Area of Science:

• Immunology
• Cellular Biology
• Biotechnology

Background:

• Conventional macroassays for cell-mediated cytotoxicity are effective but require substantial cell numbers.
• Miniaturization of immunological assays is crucial for efficiency and sample conservation.

Purpose of the Study:

• To develop and validate a miniaturized method (Microtest, MIT) for detecting natural killer (NK) and cytotoxic T-lymphocyte (CTL) activity.
• To compare the sensitivity and efficiency of MIT with the conventional macroassay (MAT).

Main Methods:

• Developed a miniaturized assay (MIT) using V-bottom microtiter plates, reducing effector and target cell numbers by 5-fold.
• Evaluated NK activity of human mononuclear cells (MNC) and performed cold-inhibition and CTL assays using both MIT and MAT.
• Assessed 51Cr recovery and compared specific lysis percentages and lytic units between the two methods.

Main Results:

• MIT demonstrated comparable sensitivity and efficiency to MAT for NK and CTL assays.
• MIT achieved a 5-fold reduction in cell requirements without altering reaction volume, improving 51Cr recovery.
• Comparable specific lysis percentages and lytic units were observed between MIT and MAT, with slightly lower slopes and acceptable r2 values for MIT.

Conclusions:

• The miniaturized Microtest (MIT) is a sensitive and efficient method for assessing NK and CTL activity.
• MIT is particularly valuable for analyzing samples with limited effector cells, such as in certain pathological conditions.
• This method offers a practical approach for studying natural resistance and CTL systems when cell recovery is a challenge.